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prevalence in the Islamic Republic 
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ABSTRACT This research compared the numbers and types of different Mycobacterium species in soil 
samples taken from 2 areas of Golestan province, Islamic Republic of Iran, 1 with a high prevalence of 
tuberculosis and 1 with a low prevalence. From 220 samples, 91 grew positive cultures (41.4%) and 161 
different strains were diagnosed. The most common species isolated were Mycobacterium fortuitum, M. 
flavescens and M. chelonae. The frequencies of environmental Mycobacterium in the low-prevalence 
area were much higher than in the high-prevalence area, perhaps due to different environmental fac­
tors. 
Mycobactéries environnementales dans des zones à forte et faible prévalence tuberculeuse en 
République islamique d’Iran 
RÉSUMÉ La présente recherche a comparé le nombre et les types des différentes espèces de Myco­
bacterium dans des échantillons de sol prélevés dans deux zones de la province de Golestan (Répu­
blique islamique d’Iran), l’une ayant une forte prévalence tuberculeuse et l’autre une faible prévalence. 
Sur les 220 échantillons, 91 ont produit des cultures positives (41,4 %) et 161 souches différentes 
ont été diagnostiquées. Les espèces les plus couramment isolées étaient Mycobacterium fortuitum, 
M. flavescens et M. chelonae. La fréquence des mycobactéries environnementales dans la zone à fai­
ble prévalence était beaucoup plus élevée que dans la zone à forte prévalence, ce qui tient sans doute 
à différents facteurs environnementaux. 
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Introduction 
There are currently 71 recognized or pro­
posed species of Mycobacterium [1], all of 
which, except M. tuberculosis complex and 
M. leprae, are considered as environmental 
mycobacteria and can usually be isolated
from environmental samples including wa­
ter, soil and dust [2]. The different environ­
mental mycobacteria are very similar and
for many years were mistakenly assumed to 
be M. tuberculosis in patients [1,2]. Nowa­
days these bacteria are believed to have
an important role in infections, allergies,
immunity to other pulmonary infections
and the efﬁcacy of bacille Calmette-Guerin 
(BCG) vaccination [3]. 
These facultative pathogens can cause
infection, especially among immunosup­
pressed or immunodeﬁcient patients [4].
Four types of opportunistic mycobacterial 
disease of humans have been described:
skin lesions (following traumatic inocula­
tion of bacteria), localized lymphadenitis,
tuberculosis (TB)-like pulmonary lesions
and disseminated disease [5]. However,
the relative incidence of the environmental 
Mycobacterium spp. involved in human
disease varies from region to region and is 
related to the occurrence of the species in 
the environment [6,7]. These bacteria are
ubiquitous, so the nature, route and dose of 
exposure to environmental saprophytes are 
variables that depend on where and how an 
individual lives. 
Another reason for the medical impor­
tance of environmental Mycobacterium
is the potential impact on the immune re­
sponse. Exposure to environmental myco­
bacteria has been suggested to inﬂuence
immune responsiveness to the pathogenic
mycobacteria and to sensitize individuals to 
skin test reagents; it can also affect the ef­
ﬁcacy of BCG vaccination [3,7–9]. Contact 
with different species of environmental My­
cobacterium can cause acquired immunity 
to M. tuberculosis or increase the efﬁcacy 
of BCG vaccine protection (M. vaccae, M. 
microti), although some species of these
bacteria reduce the efﬁcacy of BCG vaccine 
(M. scrofulaceum) [8,10–13]. 
Golestan province, which is located in 
north of the Islamic Republic of Iran, near 
the Caspian Sea, has one of the highest rates 
of incidence of TB in the country (45.5 per 
100 000). However, the distribution of TB 
is not homogenous and the incidence is
higher in the western than the eastern part 
of the province: mean incidences are 54.6 
to 28.1 per 100 000 respectively (provincial 
health centre, personal communication).
Our objective in this research was to
compare the number and types of different 
species of Mycobacterium in the soil from 
these 2 areas of the province. 
Methods 
The study took place in 2001–02. During the 
summer of 2001, a total of 220 soil samples 
were taken from humid and wet mud from a 
depth of 3–5 cm; 120 samples from 20 loca­
tions in an area of high TB prevalence in the 
western part of Golestan province and the 
remainder from 24 locations in an area of 
low TB prevalence in the eastern part of the 
province. The locations, mostly agricultural 
areas, were chosen randomly and 5 samples 
were taken from each. 
Samples were taken from upper layers 
of soil, at a depth of 5 cm, and placed in 
separate sterile glass tubes. Samples were 
transferred directly to the Microbiology
Laboratory of Golestan University of Medi­
cal Sciences. A suspension was made using 
1 g of soil in 10 mL of sterile distilled water 
containing 2–3 drops of Tween 80 [14].
The prepared suspensions were shaken for 
30 min, left for undisturbed for 30 min,
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then 3 mL of supernatant was transferred to 
another test tube and 3 mL of solution (11.7 
g/L NaOH and 5% NaHCl, ratio 6:1) added 
to decontaminate the samples. The test
tubes were centrifuged for 20 min at 2000 
rpm, then the supernatant was decanted and 
a few drops of sterile distilled water were 
added to the sediment to neutralize the sam­
ple, 200 μL of sample were inoculated in
Lowenstein–Jensen media and growths
were assessed every 2–3 days for a period 
of 1 month. The isolated colonies were as­
sessed by growth rate, morphology of colo­
ny, pigmentation in dark and light, and the 
results of a battery of standard biochemical 
tests: catalase production test at 25 ºC and 
68 ºC, growth on MacConkey agar plate,
NaCL tolerance, niacin production test, tel­
lurite and nitrate reduction test, urease test 
and Tween 80 hydrolysis [6,15]. 
Results 
From 220 soil samples, environmental my­
cobacteria were isolated from 91 samples
(41.4%). Overall 161 strains of Mycobac­
terium belonging to 12 species were iso­
lated. The isolation rate of environmental
mycobacteria in the high-prevalence area
was 20.8% (25 samples) but in the low-
prevalence area was 66.0% (66 samples).
This difference was statistically signiﬁcant 
(P < 0.05) (Table 1). 
In the high-prevalence area, 47 strains of 
environmental mycobacteria were isolated
from 25 positive samples and M. fortuitum,
M. ﬂavescens and M. chelonae were the
most common species. In 9 samples
2–5 strains were isolated. All the isolated 
Mycobacterium from this area belonged to 8 
species (Table 2). 
In the low-prevalence area, 114 strains 
belonging to 11 species were isolated from 
66 positive soil cultures, and M. ﬂavescens, 
M. chelonae and M. fortuitum were more
prevalent than other strains (23, 21 and 19 
cases, respectively). 
M. phlei were isolated from 14 soil
samples in the low-prevalence area but
were not isolated from the high-prevalence 
area. M. terrae, M. gordonae, M. kansasii
were also isolated in limited numbers from 
the low-prevalence but not from the high-
prevalence area. M. gastri was only isolated 
from the high-prevalence area (Table 2). In 
35 samples 2–6 strains were isolated. 
Discussion 
In this study in Golestan province 41.4%
of soil samples contained environmental
mycobacteria. This ﬁgure is similar to the 
results from other provinces in the north of 
the Islamic Republic of Iran bordering the 
Caspian Sea [16–18], presumably due to the 
 
Table 1 Partial distribution of positive soil culture of environmental 
Mycobacterium spp. in a Caspian Sea province in areas of high and low 
tuberculosis prevalence    
Variable High- Low- Total
  prevalence area prevalence area 
  No. % No. % No. % 
Samples taken 120  100  220 
Positive cultures 25 20.8 66 66.0 91 41.4 
Isolated species 8  11  12 
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Table 2 Partial distribution of different environmental Mycobacterium spp.
isolated from soil in a Caspian Sea province in areas of high and low 
tuberculosis prevalence   
Species High- Low- Total
prevalence area prevalence area 
No. % No. % No. % 
M. fortuitum  16 34.0 19 16.6 35 21.8
M. flavescens 10 21.2 23 20.1 33 20.5
M. chelonae 6 12.8 21 18.4 27 16.8
M. thermoresistibile 5 10.6 15 13.1 20 12.4
M. phlei – – 14 12.3 14 8.7
M. triviale  4 8.5 6 5.3 10 6.2
M. terrae – – 8 7.1 8 4.9
M. gordonae – – 4 3.5 4 2.5
M. fallax 2 4.3 2 1.8 4 2.8
M. gastri 3 6.4 – – 2 1.9
M. marinum 1 2.1 1 0.9 2 1.2
M. kansasii – – 1 0.9 1 0.6
Total 47 100.0 114 100.0 161 100.0
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similarity in climate (Mediterranean-type), 
humidity and plant ﬂora in these areas. 
In the present study, the isolation rate
of Mycobacterium spp. in the area of high 
TB prevalence (20.8%) was signiﬁcantly
lower than in the area of low TB prevalence 
(66.0%). Environmental factors are the
most likely explanation for this differ­
ence (high-prevalence areas are warmer,
dryer, further from the sea with less herbal 
coverage than low-prevalence areas). It
suggests, however, that people living in
low-prevalence areas have more contact
with environmental Mycobacterium strains 
than residents of high-prevalence areas. 
The most prevalent species isolated
from the soil in this study was M. fortuitum
complex. This is similar to Kampala’s study 
from south India [19]. Some of the isolated 
environmental Mycobacterium, such as
M. marinum, M. kansasii and some rapid-
growing species such as M. chelonae and 
M. fortuitum, can be pathogenic for humans 
[1,6]. They are almost always acquired
directly from the environment. A major
factor determining the occurrence of infec­
tions caused by the various species is their 
distribution in the environment, especially 
in water pipes [6]. As for the high preva­
lence of 2 species of M. fortuitum and M. 
chelonae in this region, physicians should 
be aware of opportunistic Mycobacterium
when encountering patients with pulmonary 
and soft tissue diseases [5,6]. 
Geographical variation in the efﬁcacy
of Mycobacterium bovis BCG vaccination
against TB is well recognized [12]. Dif­
ferent studies in human populations and
experimental studies with animals show
that infection with some environmental
mycobacteria can offer a level of protection 
against TB similar to that offered by BCG 
and that, depending on the nature of the
environmental mycobacteria and the tim­
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ing, this exposure can also enhance, mask 
or interfere with the effect of subsequent
BCG vaccination. Thus, regional differ­
ences in environmental mycobacteria ﬂora 
along with several other mechanisms could 
be responsible for the widely varying results 
of BCG trials or could inﬂuence the course 
of subsequent infection with virulent TB
bacilli [6,11,13,19]. A study in Karongadis­
trict in Northern Malawi (a region in which 
BCG vaccination has no effect against
pulmonary TB but provides over 50%
protection against leprosy) demonstrated
that prior sensitization with environmental 
mycobacteria can inhibit BCG multiplica­
tion and thereby prevent the induction of an 
efﬁcient BCG-mediated immune response
and protection against TB challenge [8].
Geographic gradients of leprosy prevalence 
are reported in Karonga District, with the
disease more common in the north than in 
the south, a pattern that may be related to 
protective mycobacterial exposure in the
low-incidence area [9]. 
The data presented in the above studies 
provide strong evidences that exposure to
various environmental mycobacteria can 
inﬂuence the immune response to BCG
vaccination and subsequent prevalence of
TB [9]. However, there have been few stud­
ies on the effect of repeated environmental 
mycobacteria contact on those individuals 
whom received earlier BCG vaccine (in
infancy) and in its efﬁcacy on inhibition
of TB. 
BCG vaccination is given to all infants 
at the time of birth in Golestan province,
and the prevalence of environmental my­
cobacteria is higher in locations of high
TB incidence than locations of low TB
incidence. This raises the question whether 
these mycobacteria can act as booster dose 
of BCG vaccine to continually stimulate the 
immune system and keep it as active form 
in case of contact with M. tuberculosis. 
Further studies are required to answer this 
question. 
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